DGIST researchers developed a deep learning model that classifies lung cancer exosomes based on physical properties measured by atomic force microscopy.
Key Details
- 1DGIST team used AFM to measure nanomechanical properties (stiffness, height-to-radius) of exosomes from NSCLC cell lines with different genetic mutations.
- 2AI model (DenseNet-121) classified exosomes by origin, achieving 96% accuracy and AUC of 0.92.
- 3Exosome stiffness reflected KRAS and EGFR mutations in their respective lung cancer cell lines.
- 4The method enables high-precision, label-free, liquid biopsy-based lung cancer diagnosis.
- 5Study published July 8, 2025, in Analytical Chemistry.
Why It Matters
This approach could offer a rapid, non-invasive way to diagnose lung cancer genetic mutations, reducing the need for tissue biopsies. Leveraging AI with nanomechanical imaging pushes boundaries in early cancer detection and personalized medicine.
Source
EurekAlert
Related News
•EurekAlert
USC Unveils Joint Biomedical Engineering Department Bridging Medicine, Engineering, and Imaging
USC's medical and engineering schools launch a joint biomedical engineering department to accelerate interdisciplinary research and innovation, including imaging and AI.
•EurekAlert
AI Predicts Risks for Outpatient Stem Cell Therapy in Myeloma
Researchers use machine learning to predict adverse events during stem cell therapy for multiple myeloma, improving outpatient safety.
•EurekAlert
AI-Enhanced CT Heart Fat Measurement Boosts Cardiovascular Risk Prediction
AI-derived measurement of heart fat from CT scans significantly improves long-term cardiovascular disease risk prediction.